Cas 617703-45-4,5-bromo-2-(2-pyrrolidin-1-yl-ethoxy)-pyrimidine

617703-45-4

Post Buying Request

Basic information

Product Name: 5-bromo-2-(2-pyrrolidin-1-yl-ethoxy)-pyrimidine
Synonyms: 5-bromo-2-(2-pyrrolidin-1-yl-ethoxy)-pyrimidine
CAS NO:617703-45-4
Molecular Formula:
Molecular Weight: 272.145
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 5-bromo-2-(2-pyrrolidin-1-yl-ethoxy)-pyrimidine(CAS DataBase Reference)
NIST Chemistry Reference: 5-bromo-2-(2-pyrrolidin-1-yl-ethoxy)-pyrimidine(617703-45-4)
EPA Substance Registry System: 5-bromo-2-(2-pyrrolidin-1-yl-ethoxy)-pyrimidine(617703-45-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 617703-45-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

617703-45-4 Suppliers

Recommended suppliers

617703-45-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 617703-45-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,1,7,7,0 and 3 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 617703-45:
(8*6)+(7*1)+(6*7)+(5*7)+(4*0)+(3*3)+(2*4)+(1*5)=154
154 % 10 = 4
So 617703-45-4 is a valid CAS Registry Number.

617703-45-4Upstream product

617703-45-4Downstream Products

617703-45-4Relevant academic research and scientific papers

NOVEL ALKYNE COMPOUNDS HAVING AN MCH ANTAGONISTIC EFFECT AND MEDICAMENTS CONTAINING THESE COMPOUNDS

-

Page/Page column 148-149, (2008/06/13)

The invention relates to alkyne compounds of general formula (I), in which groups and residues A, B, W, X, Y, Z, R1 and R2 have the meanings as cited in Claim 1. The invention also relates to medicaments containing at least one inventive alkyne. The MCH receptor antagonistic effect renders the inventive medicaments suitable for treating metabolic disorders and/or eating disorders, in particular, obesity, bulimia, anorexia, hyperphagia and diabetes.

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

-

, (2008/06/13)

The present invention relates to alkyne compounds of general formula I wherein the groups and residues A, B, W, X, Y, Z, R1 and R2 have the meanings given in claim 1. The invention further relates to pharmaceutical compositions containing at least one alkyne according to the invention. In view of their MCH-receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia and diabetes.

BENZAMIDE DERIVATIVES USEFUL AS HISTONE DEACETYLASE INHIBITORS

-

Page/Page column 74, (2008/06/13)

The invention concerns a compound of the formula (I) wherein Ring A is heterocyclyl; m is 0-4 and each R1 is a group such as hydroxy, halo, trifluoromethyl and cyano; R2 is halo and n is 0-2; and each R4 is a group such as hydroxy, halo, trifluromethyl and cyano; p is 0-4; and R3 is amino or hydroxy; or pharmaceutically-acceptable salts or in-vivo-hydrolysable ester or amide thereof processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical condions mediated by histone deacetylase

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 617703-45-4